FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087485189> ?p ?o ?g. }

• W3087485189 endingPage "1037" @default.
• W3087485189 startingPage "1031" @default.
• W3087485189 abstract "Abstract For over a century, gliomas were characterized solely by histologic features. With the publication of the WHO Classification of Tumours of the Central Nervous System, Revised 4th Edition in 2016, integrated histologic and molecular diagnosis became the norm, providing improved tumor grading and prognosis with IDH1/2 (isocitrate dehydrogenase 1 and 2) mutation being the most significant prognostic feature in all grades of adult diffuse glioma. Since then, much work has been done to identify additional molecular prognostic features, but the bulk of the progress has been made in defining aggressive features in lower grade astrocytoma. Although there have been several large case series of glioblastomas with long-term survival (LTS; overall survival ≥36 months), less is known about the clinical and molecular features of these cases. Herein, we review 19 studies examining LTS glioblastoma patients from 2009 to 2020 that include variable molecular analysis, including 465 cases with survival of 36 months or more (total n = 2328). These studies suggest that while there is no definitive molecular signature of long survival, younger age, IDH mutation, and MGMT (methyl guanine methyl transferase) promoter hypermethylation are associated with longer overall survival, and in IDH-wildtype tumors, chromosome 19/20 co-gain and lack of EGFR amplification, chromosome 7 gain/10 loss, and TERT promoter mutation are associated with LTS." @default.
• W3087485189 created "2020-09-25" @default.
• W3087485189 creator A5004524722 @default.
• W3087485189 creator A5018664498 @default.
• W3087485189 creator A5062747813 @default.
• W3087485189 creator A5065057086 @default.
• W3087485189 creator A5081784983 @default.
• W3087485189 date "2020-09-15" @default.
• W3087485189 modified "2023-10-18" @default.
• W3087485189 title "Overcoming the Odds: Toward a Molecular Profile of Long-Term Survival in Glioblastoma" @default.
• W3087485189 cites W1537699783 @default.
• W3087485189 cites W1653244371 @default.
• W3087485189 cites W1881100945 @default.
• W3087485189 cites W1966896924 @default.
• W3087485189 cites W1977199192 @default.
• W3087485189 cites W1979869169 @default.
• W3087485189 cites W1980872905 @default.
• W3087485189 cites W1988756388 @default.
• W3087485189 cites W2028196734 @default.
• W3087485189 cites W2028906953 @default.
• W3087485189 cites W2033075659 @default.
• W3087485189 cites W2041296416 @default.
• W3087485189 cites W2047299600 @default.
• W3087485189 cites W2047920989 @default.
• W3087485189 cites W2048796627 @default.
• W3087485189 cites W2052491055 @default.
• W3087485189 cites W2058562945 @default.
• W3087485189 cites W2080452140 @default.
• W3087485189 cites W2105100844 @default.
• W3087485189 cites W2106871244 @default.
• W3087485189 cites W2107007091 @default.
• W3087485189 cites W2109816625 @default.
• W3087485189 cites W2126817554 @default.
• W3087485189 cites W2154313451 @default.
• W3087485189 cites W2155268547 @default.
• W3087485189 cites W2159485898 @default.
• W3087485189 cites W2160382843 @default.
• W3087485189 cites W2227625267 @default.
• W3087485189 cites W2263206910 @default.
• W3087485189 cites W2292883121 @default.
• W3087485189 cites W2317932873 @default.
• W3087485189 cites W2366536035 @default.
• W3087485189 cites W2462300039 @default.
• W3087485189 cites W2468136639 @default.
• W3087485189 cites W2517966519 @default.
• W3087485189 cites W2566065279 @default.
• W3087485189 cites W2574587928 @default.
• W3087485189 cites W2591716768 @default.
• W3087485189 cites W2607072680 @default.
• W3087485189 cites W2608192684 @default.
• W3087485189 cites W2618667624 @default.
• W3087485189 cites W2724629974 @default.
• W3087485189 cites W2777214868 @default.
• W3087485189 cites W2781485423 @default.
• W3087485189 cites W2792738569 @default.
• W3087485189 cites W2799861331 @default.
• W3087485189 cites W2802818144 @default.
• W3087485189 cites W2864928784 @default.
• W3087485189 cites W2891763428 @default.
• W3087485189 cites W2894102714 @default.
• W3087485189 cites W2929168862 @default.
• W3087485189 cites W2942585884 @default.
• W3087485189 cites W2948665439 @default.
• W3087485189 cites W2950931626 @default.
• W3087485189 cites W2951253051 @default.
• W3087485189 cites W2965023466 @default.
• W3087485189 cites W2986804504 @default.
• W3087485189 cites W3003863259 @default.
• W3087485189 cites W3038964327 @default.
• W3087485189 cites W3041753126 @default.
• W3087485189 cites W3049768883 @default.
• W3087485189 cites W4211132876 @default.
• W3087485189 cites W564708804 @default.
• W3087485189 doi "https://doi.org/10.1093/jnen/nlaa102" @default.
• W3087485189 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32954439" @default.
• W3087485189 hasPublicationYear "2020" @default.
• W3087485189 type Work @default.
• W3087485189 sameAs 3087485189 @default.
• W3087485189 citedByCount "12" @default.
• W3087485189 countsByYear W30874851892021 @default.
• W3087485189 countsByYear W30874851892022 @default.
• W3087485189 countsByYear W30874851892023 @default.
• W3087485189 crossrefType "journal-article" @default.
• W3087485189 hasAuthorship W3087485189A5004524722 @default.
• W3087485189 hasAuthorship W3087485189A5018664498 @default.
• W3087485189 hasAuthorship W3087485189A5062747813 @default.
• W3087485189 hasAuthorship W3087485189A5065057086 @default.
• W3087485189 hasAuthorship W3087485189A5081784983 @default.
• W3087485189 hasBestOaLocation W30874851891 @default.
• W3087485189 hasConcept C104317684 @default.
• W3087485189 hasConcept C126322002 @default.
• W3087485189 hasConcept C127848430 @default.
• W3087485189 hasConcept C142724271 @default.
• W3087485189 hasConcept C143998085 @default.
• W3087485189 hasConcept C181199279 @default.
• W3087485189 hasConcept C18903297 @default.
• W3087485189 hasConcept C2777150147 @default.
• W3087485189 hasConcept C2777286243 @default.

• next